What are the key considerations during clinical trials?
Clinical trials are conducted in three phases, with each phase having specific toxicological considerations. Phase I focuses on the drug's safety and dosage, Phase II assesses efficacy and side effects, and Phase III confirms effectiveness and monitors adverse reactions. Toxicology data from these trials are critical for determining the drug's risk-benefit ratio.
